Europe's largest drug maker says investment will help meet increasing demand for its adult and pediatric vaccines, including the new cancer shot Cervarix, which is expected to gain regulatory approval in 2007. GlaxoSmithKline has been investing heavily in vaccines business and has been buying companies and technologies.
GlaxoSmithKline in France
Global pharma giant plans to invest 500 million euros in its vaccine production plant in northern France to expand capacity.
May 31, 2007
Machinery Basics
How Can You Honor a Leader?
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago
Read More
